Who invested in Xylo Bio

One round we have observed, with the 3 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

Undisclosedraised across 1 round since 2025, from 1 source

Latest round: VentureFeb 2025
Investors: 3

See who backed them

The rounds

Feb 2025
VentureAmount undisclosed
Source recorded

Founders and team

From Xylo Bio's own website: 2 founders, 10 on the team.

Joshua IsminCo-Founder, President

Dr. Sam BanisterChief Scientific Officer, Co-Founder

Dr. Jack NguyenVice President of Research & Development
Krista LicataChief Of Staff
Lisa VelardoChief Financial Officer
Dr. Alaina JasterHead Of Communications
Catherine WeeninkSenior Director, Clinical Operations
Dr. Joanna HareOperations Manager
Dr. Kelly BurkeTalent Acquisition Partner
Dr. Will JorgensenDirector Of Medicinal Chemistry
Mike LamprechtDirector
Stephane ChatonskyDirector

AdvisersDr. Gabriel VargasDr. Matthias Liechti

Everyone who backed them

GaingelsPrivate equity1round

Main Sequence VenturesVC firm1round

Possible VenturesVC firm1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

This firm lists Xylo Bio as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.